Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DosemeLOL metoprolol sex-differences pharmacokinetics pilot study
NL-OMON57425Phase 4Not yet recruiting
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of metoprolol in Atrial fibrillation (AFib), acute coronary syndrome (ACS) and myocardial infarction (MI) (2 cohorts), sponsored by St. Antonius Ziekenhuis. Primary endpoints: Area under the concentration-time curve of metoprolol, Metoprolol clearance and 5 more. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
metoprolol
03
Conditions
Atrial fibrillation (AFib)acute coronary syndrome (ACS)myocardial infarction (MI)
Beyond the preview
Go deeper on NL-OMON57425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON57425.